Clearview Wealth Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-443
Closed -$25K 358
2023
Q2
$25K Sell
443
-108
-20% -$5.95K 0.03% 251
2023
Q1
$29.8K Buy
551
+70
+15% +$3.73K 0.03% 230
2022
Q4
$25.3K Hold
481
0.02% 218
2022
Q3
$23K Sell
481
-84
-15% -$4.36K 0.02% 238
2022
Q2
$29K Hold
565
0.02% 235
2022
Q1
$34K Sell
565
-378
-40% -$22.5K 0.02% 239
2021
Q4
$62K Sell
943
-6
-0.6% -$384 0.04% 210
2021
Q3
$60K Sell
949
-59
-6% -$3.76K 0.04% 220
2021
Q2
$61K Sell
1,008
-16,320
-94% -$944K 0.04% 223
2021
Q1
$954K Sell
17,328
-9,312
-35% -$516K 0.62% 38
2020
Q4
$1.45M Buy
+26,640
New +$1.39M 0.98% 24

Other funds holding IHI

Clearview Wealth Advisors's IHI Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of iShares US Medical Devices ETF (IHI) in Q3 2023, closing a stake of 443 shares — an estimated $25K sold.

Clearview Wealth Advisors first reported a position in IHI in Q4 2020 and held it in 11 quarters. The position peaked at $1.45M in Q4 2020. 544 funds tracked by Wall St. Rank hold IHI as of Q3 2023.

  • Clearview Wealth Advisors reported no remaining iShares US Medical Devices ETF position as of Q3 2023 after selling out during the quarter.
  • Clearview Wealth Advisors sold 443 iShares US Medical Devices ETF shares in Q3 2023, an estimated $25K.
  • Clearview Wealth Advisors first reported a position in iShares US Medical Devices ETF in Q4 2020 and held it in 11 quarters.
  • Clearview Wealth Advisors's iShares US Medical Devices ETF position peaked at $1.45M in Q4 2020.
  • 544 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.